Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,145 | -9,628 | -5,957 | -2,583 | -12,386 |
| Depreciation Amortization | 45 | 32 | 18 | 4 | 15 |
| Accounts payable and accrued liabilities | 841 | 725 | 292 | 82 | -272 |
| Other Working Capital | 1,594 | 1,455 | 1,002 | 470 | -937 |
| Other Operating Activity | 2,612 | 1,911 | 1,550 | 880 | 4,031 |
| Operating Cash Flow | $-9,053 | $-5,505 | $-3,095 | $-1,147 | $-9,549 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3 | -897 | -948 | -1,999 | 1,252 |
| PPE Investments | -195 | -195 | -195 | -195 | -80 |
| Investing Cash Flow | $-192 | $-1,092 | $-1,143 | $-2,194 | $1,172 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 379 |
| Other Financing Activity | -46 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-46 | $N/A | $N/A | $N/A | $379 |
| Beginning Cash Position | 40,590 | 40,590 | 40,590 | 40,590 | 48,588 |
| End Cash Position | 31,299 | 33,993 | 36,352 | 37,249 | 40,590 |
| Net Cash Flow | $-9,291 | $-6,597 | $-4,238 | $-3,341 | $-7,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,053 | -5,505 | -3,095 | -1,147 | -9,549 |
| Capital Expenditure | -195 | -195 | -195 | -195 | -80 |
| Free Cash Flow | -9,248 | -5,700 | -3,290 | -1,342 | -9,629 |